Biofrontera Balance Sheet Health
Financial Health criteria checks 5/6
Biofrontera has a total shareholder equity of $7.2M and total debt of $1.1M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are $36.9M and $29.7M respectively.
Key information
15.4%
Debt to equity ratio
US$1.11m
Debt
| Interest coverage ratio | n/a |
| Cash | US$10.39m |
| Equity | US$7.17m |
| Total liabilities | US$29.73m |
| Total assets | US$36.91m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AI10's short term assets ($32.3M) exceed its short term liabilities ($25.4M).
Long Term Liabilities: AI10's short term assets ($32.3M) exceed its long term liabilities ($4.4M).
Debt to Equity History and Analysis
Debt Level: AI10 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if AI10's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AI10 has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: AI10 is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.